Femoral Arteriotomy Closure

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

TM
Teleflex MedicalAustralia - Mascot
2 programs
MANTA Vascular Closure DeviceN/A1 trial
MANTA Vascular Closure DeviceN/A1 trial
Active Trials
NCT05936996CompletedEst. Oct 2025
NCT05142566TerminatedEst. Jan 2023

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Teleflex MedicalMANTA Vascular Closure Device
Teleflex MedicalMANTA Vascular Closure Device

Clinical Trials (2)

NCT05936996Teleflex MedicalMANTA Vascular Closure Device

Prospective Clinical Registry Evaluating Contemporary MANTA Outcomes

Start: Nov 2023Est. completion: Oct 2025
N/ACompleted
NCT05142566Teleflex MedicalMANTA Vascular Closure Device

MANTA Ultrasound Closure Study

Start: Aug 2022Est. completion: Jan 2023
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space